Sarepta Shares Jump After FDA Approves Updated Elevidys Label

All NewsNovember 15, 2025

Sarepta Therapeutics shares jumped after the FDA issued a new boxed warning for Elevidys.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent